This inventor holds 1 USPTO granted patent. Top assignee: Augusta Spinco Corporation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Sebastien Simard: Inventor in Diagnostic Testing
Introduction
Sebastien Simard is an inventor associated with Quebec, Canada. His work includes a patent concerning nucleic acid-based testing for vaginal disorders and the challenge of maintaining reliable results when clinical samples contain interfering substances.
Latest Patents
Simard is listed as an inventor on 1 patent, titled “Buffer Compositions for Reducing Aggregation.” The patent describes compositions, kits, and methods for nucleic acid-based detection and identification of vaginal disorders, including vulvovaginal candidiasis, trichomoniasis, and bacterial vaginosis. The disclosed approaches are intended to support robust diagnostic performance in the presence of interfering substances, such as gels found in clinical vaginal-swab samples.
Career Highlights
Simard is associated with Augusta Spinco Corporation. His patent work focuses on buffer compositions and diagnostic methods designed to address practical challenges in testing clinical samples.
Collaborations
The provided information identifies Sebastien Morasse and Marie-Helene Tremblay as Simard’s coworkers. Their names are also associated with the collaborative context of his work.
Conclusion
Sebastien Simard’s patent highlights an effort to improve nucleic acid-based testing for vaginal disorders by helping diagnostic methods perform reliably despite sample interference.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile